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Abstract 
Fibrin microthreads are a biological material being examined for use in a targeted 
cell delivery system, but sutures created from the threads exhibit a variance in their 
mechanical properties. A mechanized and standardized fibrin microthread bundling device 
was designed and constructed to achieve the goal of producing consistent and reproducible 
microthread bundles. This was achieved by a rotating set of disks which combined the 
threads through a simple twist mechanism. The resulting bundles were compared to hand-
made bundles through mechanical properties and cell seedability, with additional 
prototype measurements for thread twist consistency. Hand-twisted samples were 
calculated to have a YS, UTS, and E of 0.390 ± 0.190, 1.066 ± 0.678, and 0.405 ± 0.168 MPa, 
respectively. Prototype produced bundles were found to have a YS, UTS, and E of 0.196 ± 
0.050, 0.537 ± 0.181, and 0.269 ± 0.158 MPa respectively. Additional prototype twisted 
bundles were found to contain an average of 1.65 ± 0.5 twists per cm. Average values for 
bundle mechanics were found to be lower for prototype produced bundles. Standard 
deviations were also lower though, suggesting more consistent bundle production. 
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Chapter 1: Introduction 
Fibrin microthreads are made from the crosslinking of fibrinogen and thrombin. 
Fibrin is a natural provisional matrix for cell attachment and migration during wound 
healing and has been used in the form of hydrogels and microthreads for cell delivery to 
target areas. This can lead to the restoration of skeletal muscle defects, as fibrin 
microthreads have been shown to increase healing outcome for a variety of wound types 
(Page et al, 2011). Fibrin microthreads have also been shown to support fibroblast 
attachment, proliferation, and alignment, suggesting that they represent a viable 
biomaterial in tissue regeneration (Cornwell and Pins, 2007). The current process of 
making these fibrin microthreads can be automated or manual by drawing the tube of 
fibrin in a series of lines through a pan of solution. Once solidified, the threads are taken 
out to dry and are readied for the bundling process to turn them into microthread sutures 
(Cornwall and Pins 2007).  
 Currently there is no mechanical device or system to bundle, by twisting or braiding, 
the microthreads into bundles and ultimately sutures; therefore, this process is done by 
hand, which leads to bundle inconsistencies. Our goal is to design a fibrin microthread 
bundling device that will improve the current process of making the bundles by easily 
attaching to the surgical needle, maintain similar properties to the current suture, have 
consistent suture production, be easy to manufacture, and be user-friendly. 
 There is also a clinical need for cell delivery via fibrin microthreads. Since these 
microthreads are composed of biocompatible and biodegradable biomaterials, they can be 
seeded with human mesechymal stem cells (MSCs), which can then be sewn into the target 
area to deliver the cells to a specified area. A previous team has shown that the fibrin 
microthread sutures can in fact be seeded with MSCs, and still maintain their multipotency 
(Kowaleski, 2012). 
 During this MQP, our team will design and build a prototype of our suture maker 
and test the mechanical properties as well as the cell seedability of the produced bundles. 
In addition to building a prototype we will model our design in CAD and complete 
mechanical and cell seedability testing of the current handmade sutures for comparison to 
our produced sutures. 
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Chapter 2: Background 
Each year, 715,000 Americans suffer from a heart attack, and 600,000 die from all 
types of heart disease (CDC site, Heart Disease Facts). Heart attacks occur when blood flow 
has been cut off in one of the coronary arteries, resulting in myocardial infarction. When 
this happens, the cardiac muscle cells in the heart can die, resulting in a partially dead heart 
that is not operating at full capacity. As a result, studies have been conducted in an effort to 
develop methods to rejuvenate the damaged heart tissue and restore a patient’s health. 
2.1 Mesenchymal Stem Cells 
 Recently, cell-based therapies have become very popular in regenerative medicine. 
Mesenchymal stem cells, known as MSCs, are most commonly used in studies and research 
due to their ability to differentiate into other various types of cells and the fact that they 
can be found throughout the body (Barry & Murphy, 2003). These cells can be isolated 
from various tissues such as adipose tissue, peripheral blood, umbilical cord and placenta, 
as well as bone marrow (Barry & Murphy, 2003). They also have a remarkable capacity of 
extensive in vitro expansion which allows them to rapidly reach the desired number for in 
vivo therapy (Wang et al, 2012).  
 MSC's have been used to treat different kinds of problems like graft-verus-host 
disease, cardiovascular repair, skeletal muscle repair, liver disease and many others (Wang 
et al, 2012). The International Society even has defined MSC's by three criteria: 
 (1) MSCs must be adherent to plastic under standard tissue culture conditions. 
 (2) MSCs must express certain cell surface markers such as CD73, CD90, and CD105, 
 and lack expression of other markers including CD45, CD34, CD14, or CD11b, 
 CD79alpha or CD19 and HLA-DR surface molecules.  
 (3) MSCs must have the capacity to differentiate into osteoblasts, adipocytes, and 
 chondroblasts under in vitro conditions.  (Wang et al, 2012) 
MSCs can be obtained in more sufficient numbers for effective clinical treatment 
than other cell candidates such as cardiac stem cells and fetal cardiomyocytes, and thus 
have emerged as a potential cell type for different types of tissue repair (Murphy et al, 
2008).  
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As the MSCs are able to differentiate into such a wide range of cell lines, they are useful in 
many regenerative medicine applications. These cells can be applied for the healing of 
several tissue types, and experiments have been conducted to evaluate the effect of the 
introduction of MSCs to damaged areas of the body. Areas seen to benefit from the stem cell 
therapy include nerve injury, skin graft survival, skeletal muscle defects, and damaged 
cardiac muscle. 
2.1.1 MSC Regenerative Applications 
For nerve cell healing, there has been work done with the neuro-regulatory 
molecules BDNF and β-NGF, which are expressed by certain MSC subpopulations. These 
neurotrophins were shown to correlate with the ability of the cells to assist in the survival 
and neurite formation in neuroblastoma cells and peripheral neurons within DRG explants 
(Crigler et al., 2006). The MSCs were also seen to secrete the glycoprotein prosaposin and 
the cytokine pleiotrophin. Though the effect of these molecules was not directly studied, 
they have been seen to stimulate neurite outgrowth in previous studies (O’Brien et al., 
1994), (Li et al., 1990). 
Further uses of MSCs have been examined and highlighted through their effect on 
skin graft survival in a primate focused study. An experiment was conducted to understand 
the relationship between the activities of MSCs in the bone marrow and a potential 
immunomodulatory effect on lymphocytes (Bartholomew et al., 2001). It was seen that 
baboon MSCs had suppressed the proliferative activity of allogeneic peripheral blood 
lymphocytes in vitro. When a single dose of MSCs was delivered intravenously, 
transplanted skin grafts were seen to have a statistically greater duration of skin graft 
survival. 
For use in skeletal muscle defects, studies have been conducted to understand the 
roles of MSCs when applied to muscle tissue. Adult human synovial membrane-derived 
MSCs that were known to have myogenic potential in vitro (De Bari, et al., 2001) were used 
for skeletal muscle regeneration in a nude mouse model. The hSM-MSCs were seen to 
contribute to myofibrils and long-term functional satellite cells (De Bari et al., 2003), and 
were also characterized as being sensitive to environmental cues in the body. 
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2.2 Myocardial Infarction Treatments 
With the mesenchymal stem cells showing such promise in tissue healing, they were 
seen as a potential treatment for the regeneration of hearts subject to myocardial 
infarctions. In humans specifically, cardiac tissue has low natural regeneration (Laflamme 
& Murry, 2011) and is slow to heal on its own. In addition, the therapies for the infarctions 
are limited and not as effective as they could be. As a result, the application of MSCs to 
damaged cardiac tissue has been studied as a novel treatment option. 
Studies have been conducted to evaluate the effects that the stem cells have on the 
infarcted tissue, and to show the beneficial effect they have. Applications methods vary, but 
have included intravenous (IV) cell delivery, intramyocardial (IM) injection, intracoronary 
(IC) cell delivery, and cell seeded scaffolding. These delivery methods result in varying 
levels of success in partial cell engraftment for each distribution mode. 
For IV cell delivery, a study examined the delivery of bone marrow derived 
mesenchymal stem cells (BM-MSCs) for myocardial repair after infarction. The BM-MSCs 
were procured from rat bone marrow, and were transfused into the left ventricular cavity 
of the rats. The cells were found to have a retention in the heart of less than 1% in the first 
hours after transplantation, most cells were found to coalesce within the lungs, with 
additional cells found in the liver, spleen, and bone marrow (Barbash et al., 2003) 
Further studies were completed on the distribution of peripheral blood 
mononuclear cells (PBMNCs) after being delivery to the heart by different means. For IM 
injection, the anterior surface of the heart was exposed through opening the pericardium, 
and a suspension of cells was injected at 10 evenly spaced sites in the anterior left 
ventricular wall. This method was found to result in 26% of the cells found in the lungs, and 
11% retained inside the myocardium. For IC delivery, an angioplasty balloon was inflated 
at low pressure inside the infarcted artery, and cells were infused over 30 to 45 seconds, 
with the balloon being deflated after 3 minutes. The IC cell delivery lead to 47% of the cells 
localized in the lungs, with a 2.6% retention of cells in the myocardium. In both 
experiments, the animals were euthanized one hour after cell delivery to evaluate the cell 
retention rate (Hou et al., 2005). 
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As an alternative to the stem cell injections, an epicardially applied cardiac patch, 
which contained human-MSCs, was used to evaluate the potential for increased exogenous 
cell engraftment. The hMSCs were embedded into a type I collagen matric obtained from a 
rat tail, and the patch was then secured to hearts with fibrin sealant after induced 
myocardial infarction. The patch was found to have a cell engraftment of 23% after 1 week 
in the body, after the patches were cultured for 4 days (Simpson et al., 2007). Though more 
effective than other treatment options, the graft is not able to properly aid in the 
regeneration of the cardiac tissue on the inside of the heart walls. 
The research has shown that stem cells can be applied to damaged areas of the 
heart, but such procedures can often lead to the presence of the stem cells in other non-
targeted areas. The movement of the MSCs in itself does not pose a large risk, but allowing 
the cells to circulate throughout the body may have detrimental effects on the patient. 
Studies have proven that MSCs may affect cancer progression, with experiments showing 
cancer growth initiation in vivo, and cell transformation into malignant cells in vitro, though 
no definite evidence supports spontaneous in vitro human MSC transformation (Torsvik & 
Bjerkvig, 2012). 
Further work has been done to develop a method of localized stem cell delivery for 
an additional way to administer cells for cardiac muscle cell regeneration. Fibrin 
microthreads were created through an extrusion of fibrinogen and (thrombin from bovine 
plasma), and were then bundled together in groups and then seeded with MSCs for cell 
delivery (Proulx et al., 2010). The bundles are then attached to a needle and recombined to 
create a biological, cell seeded suture. The suture is transplanted into the heart at the site of 
damage, and removed at a later time. This method was seen to result in a cell delivery 
efficiency of 63% in vivo, 1 hour after suture implantation (Guyette et al., 2012). 
2.3 Biological Value of Fibrin 
Within the body, fibrinogen and thrombin react as part of the wound-healing 
cascade. The reaction of these two compounds, in conjunction with production of platelets, 
produces a provisional extracellular matrix. Ultimately, it is through this process that fibrin 
clots are able to form. When this is reproduced in vitro, the produced fibrin clots have poor 
mechanical properties because the structure of natural in vivo fibrin is amorphous 
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(Cornwell, 2007). In order to take advantage of the wound-healing characteristics of fibrin, 
the compound must be modified in order to be successful.  
2.4 Fibrin Microthread Production 
The fibrin microthreads used for our project were produced by VitaThreads using a 
modified automated version of the procedure described in the Kornwell and Pins’ 2007 
article (Kornwell  & Pins, 2007). A set of two 1 mL syringes, one of fibrinogen and the other 
of thrombin are coextruded using a control syringe pump at a constant rate. The two 
solutions are then combined within the blending connector, which is then extruded 
through a single needle into a polyethylene tube into a bath. The threads are left in the bath 
to allow for the complete polymerization of the fibrin. The fibers are then removed from 
the bath and air-dried on the rack.  
2.4.1 Fibrin Microthread Bundling Process 
From these threads, bundles are produced. Bundles consist of a group of threads 
that have been carefully twisted and bound together using the attachment properties of the 
threads when exposed to water. VitaThreads currently uses a method of taping either end 
of a group of dry threads and twisting until there is approximately one twist per cm. Once 
the bundle is twisted, the bundle is then hydrated and then left to dry. Once dry, the bundle 
is thenthreaded through a surgical needle. The bundle is finally doubled over bundle is then 
twisted again, in the counter direction of the original twist, to produce a combination Z and 
S twist.  Alternate processes for the bundle making process include wetting the threads for 
the duration of the twisting process, although no studies has been done to determine if 
there are any differences in the bundles produces from these processes.  
2.5 Physical Properties of Fibrin Microthreads 
The physical properties of fibrin microthreads have been thoroughly researched. 
Previous studies have reviewed the mechanical properties and cell seedabililty of both the 
threads and bundles (Proulx et al., 2010, Guyette et al., 2012). Other studies of the threads 
have reviewed the effects of crosslinking and other potential strengthening techniques to 
the microthreads (Cornwell & Pins, 2007, Graman et al, 2012).  
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2.5.1 Mechanical Properties of Fibrin Microthreads 
There have been several different studies done to review the mechanical properties 
of fibrin microthreads. Due to the significant differences in mechanical properties of fibrin 
microthreads, the process by which the threads were produced has had a significant impact 
on their mechanical properties. Previous published studies have shown that the threads 
have significantly different moduli depending on the diameter (Cornwell & Pins, 2007, 
Grasman et al, 2012). Through the automation of the thread making technique that 
VitaThreads currently uses, in addition to standardizing the bundling process through this 
project, the variability in mechanical properties should be minimized. In previous studies 
of fibrin microthreads, mechanical properties have been measured using a series of 
uniaxial loading Instron tests. Through the stress-strain curves the failure strain (FS), 
ultimate tensile strength (UTS), and the maximum tangent modulus (E) were calculated for 
the bundles (Cornwell & Pins, 2007). The calculated results found the FS, UTS, E to be 0.31 
± 0.15 (mm/mm), 4.48 ± 1.79 (MPa), and 60.70 ± 2.71(MPa) respectively (Cornwell and 
Pins, 2007).  
2.5.2 Cell Seedability of Fibrin Microthreads 
Several previous studies have detailed the cell seedabillity and cell proliferation of 
cell attached to fibrin microthreads. Following standard cell seeding and passaging 
techniques to the microthreads, live/dead cell viability stains were conducted at days 1 and 
7 or 3 and 7 (Cornwell & Pins, 2007, Grasman et al., 2012).  
2.5.3 Effects of Crosslinking on Fibrin Microthreads 
 In an effort to strengthen fibrin microthreads, research has been done to study the 
effects of typically strengthening techniques such as UV light exposure. UV exposure 
proved to increase several mechanical properties of the threads, such as the ultimate 
tensile strength (UTS), but had negative effects on cell proliferation and thread swelling 
(Cornwell & Pins, 2007). Different methods of crosslinking have been shown to have little 
to no effect on cell proliferation and cell viability, two of the factors that had previously 
been impacted (Grasman et al., 2012).  Ultimately, more research is needed to determine if 
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the positive effects of some methods of UV crosslinking can be exploited for use in 
microthread sutures to enhance mechanical properties.  
2.6 Suture Production 
The existence of sutures has been prevalent in the medical industry for thousands of 
years. In ancient India, physicians used the heads of beetles or ants to effectively staple 
wounds shut (Inc, 2013). The live creatures were affixed to the edges of the wound which 
they clamped shut with their pincers. The bodies of the insects were removed and mouths 
left behind fastening the wound together as seen in Figure 1. Doctor’s also utilized flax, 
hair, grass, cotton and silk as natural material sutures.  
 
Figure 1: Ant heads used as ancient sutures (by Van Thi Hong Tran, 23 May 2012, vanttran.tumblr.com 23 May 
2013.) 
Sutures are designed for different applications with varying qualities. In this 
research paper the team is investigating a means to design and build a machine capable of 
twisting or braiding fibrin microthreads embedded with hMSC stem cells into a bundle for 
treatment and regeneration of cardiac infarctions. In this section we explore methods that 
are used in the textile industry to twist and braid certain materials into fabric. 
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2.7 Current Thread and Rope Making Processes 
The overall process in making a suture is very similar to the methods used in the 
textile industry. In the manufacturing process the first step is the production of raw 
polymer. The raw polymer is then forced through a die and discharged as tiny pellets. The 
pellets are then placed in an extrusion machine and form individual filaments. Filaments 
are stretched between two rollers. Some sutures are manufactured as monofilaments and 
others are braided or twisted. In order to braid a suture the extruded filament can be 
wound onto bobbins. The bobbins are loaded onto an automatic braiding machine. The 
process here does not require a lot of human intervention only to the point of accessing the 
machines workability. After filaments are braided a number of secondary processing steps 
are carried out depending on the type of bundle being manufactured. Each bundle is 
inspected for either heat-treated or to be hydrated until desired suture is produced. A 
quality inspection is done to evaluate the diameter, length, and strength of the bundle. Next 
the bundle is attached to a needle and packaged. The needles are usually produced at 
another manufacturing plant. The final packaged suture is sterile and ready for surgery. 
2.7.1 Braiding Machines  
Strand-forming braiding machines have horn gears arranged on a braider table.  The 
gears turn in opposite direction. This is necessary for the drive mechanism of the bobbins. 
In accordance with the number of reparations the bobbin feet are taken from the 
neighboring horn gear to the next one to pass them on. This means that the bobbin 
alternatively uses the front and back of subsequent horn gears. A wavy movement path is 
cut in the braider table underneath the horn gears. The sliding shoes of the bobbins move 
in that groove and guide the bobbins along the closed path. Each bobbin therefore moves 
around each horn gear. Intersection of the braiding threads develop at the cross spots of 
the cut path by simultaneous movement to the left or to the right of one half the bobbins 
(Burkhard Wulfhorst, 2006). Circular braids can be produced by a closed horn gear 
arrangement. The bobbins move on two closed paths rotating around the center. One part 
of the bobbins moves to the left and the other moves to the right, as seen in Figure 2. 
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Figure 2: Schematic diagram of circular braiding arrangement (Burkhard Wulfhorst, 2006. 23 May 2013). 
2.7.2 Maypole Braiding Technique 
The invention of a commonly used technique to braid individual threads into a 
braided rope is known as a Maypole Braid, this type of braiding technique is utilized in 
textile, marine and suture industry to manufacture desired braiding arrangement. The 
methods employed and the apparatus utilized in producing a conventional two over, two 
under braid vary to some degree. A Maypole or sinuous braiding technique optimizes 
wherein the strand carriers are moved in intersecting serpentine paths on a braiding deck 
as the strands are let off under tension onto the tubular structure to be reinforced which is 
pulled at a uniform rate in a direction perpendicular to the deck (Richardson, 1993). 
Although early forms of Maypole braiders utilized various mechanisms for driving the 
carriers in opposite directions around sinuous tracks mounted on the braider deck, 
modern Maypole braiders utilize planetary gearing and a cam track and cam follower 
system on the carriers and drivers to eliminate the sinuous tracks and their attendant high 
friction and wear problems. Figure 3 below highlights the design of the gear and sprocket 
assembly of a machine that utilizes this technique. 
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2.7.3 Marine Industry Techniques 
The marine industry requires the use of high strength ropes for use in daily 
activities. High modulus synthetic fibers have been commercially available for over (40+) 
years, starting with Kevlar® aramid. In addition to Kevlar and other aramids such as 
Technora®, HMPE (Spectra® and Dyneema®) and Vectran® Liquid Crystal Polymer (LCP) 
fibers are now also utilized in high performance ropes, with HMPE constructions proving to 
be the most versatile across a broad range of applications. Synthetic fiber rope 
constructions made with these types of materials can equal or exceed the tensile strengths 
of steel wire ropes (Greenwood, 2006). 
 
  
Figure 3: Maypole Braiding Machine Gear and Sprocket Assembly 
(http://www.instructables.com/community/Can-anyone-build-a-hand-crank-
braiding-machine-S/). 
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Chapter 3: Project Strategy  
In order to create a complete project strategy for a fibrin microthread bundling 
device, the team needed to interpret and revise the initial client statement as well as 
develop objectives based on a qualitative assessment of the important goals for the project. 
From the revised client statement and clearly defined objectives and goals, the team was 
able to derive the functions of the device. With this information the team was able to gain a 
complete understanding of the problem statement and was able to develop preliminary 
designs and experiments and test design concepts.  
3.1 Initial Client Statement 
During the team’s first meeting with Prof Gaudette, they were given the challenge of 
developing a device to consistently bundle fibrin microthreads for suture production.  
The following was the initial client statement: 
 
“Design a device/system to reproducibly create a biological suture from 
fibrin microthreads. The system should allow for different numbers of 
fibrin microthreads to be used, be user friendly and not have detrimental 
effects on the fibrin microthreads.” 
 
Although there is currently a handmade method for producing fibrin microthread 
bundles in use, there are several inconsistencies associated with this bundling process that 
prevent it from being applied to large-scale commercial operations. From the initial client 
statement and the team’s comprehensive understanding of the problem at hand, the team 
was able to develop a project strategy and refine a list of objectives and functions. 
3.2 Design Objectives and Constraints 
 Based off the team’s initial design meetings and tour of the VitaThreads’ lab space, 
the team developed a list of objectives and constraints for the design. These objectives 
were based off of the team’s background research and discussions with Prof Gaudette and 
the client, Adam Collette the President of VitaThreads, as well as potential users, members 
of the Gaudette Lab and the VitaThreads production team. 
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3.2.1 Initial Design Objectives 
The five primary objectives that the team identified, in no particular order, were:  
 Easily attachable to a surgical needle 
 Maintain similar physical properties to current sutures  
 Produce consistent bundles 
 Easy to manufacture 
 User friendly 
 
Under maintaining similar physical properties, three types of properties were 
identified, cell seedabililty, biocompatibility, and mechanical properties. Under 
manufacturability, two secondary objectives of inexpensive production as well as can be 
scaled-up for commercial production were identified. Finally, safety and easy to use were 
identified as the secondary objectives for the user-friendly objective. An objective tree of 
the team’s primary and secondary objective can be seen in Appendix A: Design Objectives 
Tree. 
3.2.2 Qualitative Assessment of Objectives 
 Once the team had fully developed, defined, and grouped the objectives, it was 
necessary to compare these objectives to each other in order to determine the most 
important objectives and to revise the client statements. In order to rank these objectives 
against each other, a pairwise comparison chart was used to determine the ranking. 
Pairwise comparison charts were given to the project advisor, the client, as well as 
potential users within the VitaThreads and Gaudette labs, totaling 5 responses. The 
pairwise comparison chart used each of the five primary objectives and compared them to 
each other. The chart only allowed for two responses, either a ranking of more important 
or less important. The objective in the horizontal row received a score of 1 over the 
objective in the vertical column if was more important and alternatively, a score of 0 if it 
was less important. The scores for each objective were counted horizontally across the 
chart, with the highest score ranking first and the lowest score ranking fifth.  
In the case of two objectives receiving the same the ultimate total score, the ranking 
between those two objectives was revisited and the objective with more importance 
received the higher overall objective ranking. Upon receiving the completed pairwise 
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comparison charts, the team scored and the average ranking of the objectives was 
determine. The averaged results for pairwise comparison charts that the team handed-out 
to the clients, project advisors, and potential users can be seen in Table 1 and the team’s 
ranking of the objectives of can be seen below in Table 2.  
 
Table 1: Averaged objectives ranking from outside opinions 
Ranking Objective 
1 Produces consistent sutures 
2 Maintains similar properties 
3 User friendly 
4 Attaches easily to needle 
5 Manufacturability 
 
Table 2: Team's objectives ranking 
Ranking Objective 
1 Produces consistent sutures 
2 Maintains similar properties 
3 Attaches easily to needle 
4 User friendly 
5 Manufacturability 
While Table 2 represents the average ranking, there were significant differences in opinion 
by the stakeholders as to the ranking of certain objectives. One such disparity was that the 
client ranked manufacturability as most important, while the averaged ranking for this 
objective was last. This reinforced the team’s understanding that for the client, the ability 
to manufacture and integrate the device into their current operation was of the utmost 
importance. 
In general, the team’s ranking was mostly in line with the average ranking of 
surveyed individuals, as seen in Table 1 and Table 2; the only difference was that user 
friendliness ranked higher than needle attachment. From this, the team recognized that the 
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user-friendly objective should be reviewed and highly considered throughout the design 
process.    
3.2.3 Design Constraints 
The team developed a set of initial constraints for the design based off the meetings 
with Prof Gaudette and VitaThreads employees. The initial constraints developed can be 
seen in Table 3 below. 
Table 3: Initial Design Constraints 
Constraint Definition 
Money Budget of $624 
Size Must fit on lab bench 
Time Must be finished by end of E Term 2013 
Safety Must be safe for user 
Materials Must be non-reactive 
 
The budget for this project was determined by the BME department budget per MQP team 
member of $156, giving the team $624 for the project. Through the team’s visit to the 
VitaThreads lab space, it was determined that the device must be small enough to be stored 
on the lab bench. Since this project was conducted during E-Term, the entire project must 
be completed within a seven-week time frame, ending on June 28, 2013. The team also 
considered that materials that the device could be made from. The materials that the 
microthreads would come in contact with could not have any harmful or detrimental 
effects on the bundles being produced.  
3.3 Revised Client Statement 
After completing background research and developing the objectives for the project, 
the team revised the client statement to reflect the goals of the project as the team 
identified them. The revised client statement is as follows:  
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Design a device/system to easily produce uniform biological sutures from 
fibrin microthreads with a consistent amount of twists per unit length. The 
system should bundle a range fibrin microthreads, be user friendly, be 
inexpensive to manufacture, and should not significantly impact the 
physical properties of the final suture. The resulting bundles should also be 
able to easily interfaced with a surgical needle. 
3.4 Design Functions and Specifications 
 Using the information learned for the literature as well as the refined understanding 
of the problem through clear objectives and client statements, the team was able to develop 
a comprehensive list of functions and specifications for the device.  
3.4.1 Functions 
To determine the functions of the device, the team answered the question “What 
must the device do?” and developed the list of the following functions: 
Functions 1: The device must produce a consistent twist or braid 
throughout the length of the sutures. 
 
Function 2: The device must securely attach the microthreads and feed them 
into the bundling process. 
 
Function 3. The device must continuously hydrate the microthreads. 
 
Function 4: The device must make the microthreads handleable for 
bundling. 
 
Function 5: The device must be user friendly and safe. 
 
Function 6: The device must quickly produce bundled microthreads. 
 
Function 7: The device must produce a bundle that can be easily attached to 
the surgical needle. 
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Function 8: The device must not significantly degrade the mechanical 
properties of the microthread bundles. 
 
Function 9: The device must not significantly degrade the cell seedability of 
the microthread bundles. 
 
Function 10: The device must produce microthread bundles that can be 
easily stored. 
 
Function 11: The device must produce microthread bundles that can be 
easily sterilized.  
3.4.2 Design Specifications 
Based off of the functions, the team developed a set of specifications for the design. 
The limitations that the team faces with the design project are time, the small size of 
threads being bundled, the delicate nature of the individual fibrin microthreads, the length 
of each thread, and the budget given to the team. Taking into account the objectives, 
functions, and limitations the team has developed specifications for the device. The major 
specifications for the design are shown below. These were developed to achieve the 
specific needs of the design taken from the objectives and functions developed by the team. 
A full list of all specifications for the design can be found in Appendix B: Design 
Specifications. 
 
Produces bundles that can be made into sutures of at least 4 cm in length 
Can bundle 1-24 microthreads 
Can bundle microthreads of approximately 12 inches in length 
Take a maximum of 30 minutes to produce a bundle 
Produce approximately 1.5 twists per cm 
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Chapter 4: Alternative Designs 
4.1 Needs Analysis 
 In order for the team to create a sound design the team had to answer the question 
of what the actual needs of the design were. Revising the client statement from the team’s 
understanding of the clients wants was the first step taken. The team was also able to 
further refine the system’s needs through bi-weekly meetings with professor Gaudette, an 
interview with Adam Collete, president of VitaThreads, and ranking of objectives from 
pairwise comparison chart handed out to the members of the Gaudette lab and VitaThreads 
employees. After reviewing the client statement and collecting the results from the 
pairwise comparison charts the team ranked the objectives, as shown previously in Table 
2.  The team also created a list of functions that the device must achieve. The list is 
highlighted in Section 3.4.1 Functions. The device must hydrate the threads as they are 
consistently twisted or braided into a bundle. The device must be user friendly and safe. 
Other important functions of the device is that they should produce a bundle that is easily 
stored, sterilized and can be easily attached to a surgical needle without degrading the 
mechanical properties of the threads. The limitations that the team faced with this design 
project were time, the small size of threads being twisted or braided, the delicate nature of 
the individual fibrin microthreads, the length of each thread and the budget given to the 
team. A Needs Analysis was conducted to better understand the requirements and 
specifications of the system. To do this, the design team identified objectives and classified 
them under “needs” and “wants”. A system need was defined as a crucial system function 
that must be met for the system to be considered a success. A system want was defined as a 
desired objective by the user and client, but did not have to be met for success. The 
objectives developed by the team were broken up into system needs and system wants of 
the design and can be seen below in Table 4.  
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Table 4: Needs and wants for the system. 
Needs Definition 
Reproducible Ability of the system to produce thread bundles 
which have consistent bundle to bundle 
structural and mechanical properties 
Precise Ability of the system to produce thread bundles 
which have consistent spacing between each 
twist 
Minimize thread failure Ability of the system to minimize thread failure 
during production  
Automated Stretching Ability of the system to hold the threads in 
tension while bundling occurs 
Modifiable amount of threads Ability of the system to produce bundles with 
different number of threads 
Wants Definition 
Sterilization Ability all parts of the system to be sterilized 
Attach to the Needle Ability for the system to attach the bundle to the 
needle 
Manufacturability Ability of the system to be scaled up 
 
Systemic Needs 
Pairwise comparison charts evaluated by the user, client, and design team were 
analyzed and quantified to create a list of systemic needs. “Reproducibility” and “Precision” 
were two objectives classified as systemic needs since the final design must produce thread 
bundles that have the same structural and mechanical properties as well as have consistent 
spacing between each twist within the braided bundle. The system must also be able to 
maintain tension while minimalizing thread failure during production and thus are also 
classified as systemic needs. The system as requested by the client and user should be able 
to have a modifiable amount of threads when bundling. This objective is classified as a 
systemic need as the design must be able to produce bundles with varying number of 
threads. 
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Systemic Wants 
 Understanding the needs for the system was important, but understanding the 
wants was almost equally as important during the design process. Although needs were 
essential the objectives which should be met for a successful project, wants were objectives 
which would ideally also be met. Wants were classified during meetings with the client and 
user as well as through the analysis of objectives. 
 Manufacturability and an attachable interface of the bundle to the needle were 
identified as wants. The secondary objective of interfacing the twisted bundle with the 
surgical needle would make the overall design more complicated, and due to the time and 
budget constraints, out of the realm of this project. These objectives were not essential in 
terms of device success, but would be included in an ideal system. For the system to be 
ideal it would need to have the ability to be scaled up and interface with the suture needle, 
and produce sutures consistently but due to limitations highlighted above they were 
identified as wants. Sterilization was also identified, as an objective want for the system. 
The primary goal of the system was to produce and consistently bundle threads while 
minimizing thread failure. However, in an ideal system, the threads would be produced and 
modified in terms of sterility for other experimental needs, which did not fall within the 
scope of this project. 
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Table 5: System Design Matrix 
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Size of system           X    X 
Thread 
Capacity 
X X     X   X   
Maximum 
Stress on 
threads 
  X  X X     X   
Maximum 
Stretch of 
threads 
  X  X X         
Spacing 
between 
Individual 
Twist 
X X            X 
Finite Thread 
Length 
X     X        X 
Bundling Time X X           X 
 
As shown above in Table 5, the matrix compares needs and wants with 
corresponding systemic specifications. The columns denote the identified needs and wants 
for the system, whereas the rows denote specific design criteria. An X denotes affected 
objectives by the design criteria. For example, the specification for the ‘maximum stress on 
the threads’ directly affects the needs ‘minimal thread failure’ and ‘automated stretching’ as 
well as the want of ‘manufacturability’ for the system. Because the ‘minimum thread 
 30 
failure’ and ‘automated stretching’ of the threads were identified as needs, the stress on the 
threads must not prevent these objectives even at the cost of manufacturability. The 
purpose of this design analysis was to identify the relationships between specific designs 
and the needs and wants of the system. 
4.2 Conceptual Designs 
 In the process of designing a suitable device that would be able to conform within 
the desired objectives, constraints, functions, and specifications, several preliminary design 
concepts were discussed and considered along the way. As the two primary functions that 
were identified were the bundling mechanism and the hydration mechanism, the potential 
means for achieving these functions were often the focus for the conceptual designs. 
 Possible means for the bundling of individual threads included twisting the threads 
or braiding the threads. Either system could be modified based upon the desired number of 
threads to be included, the number of threads paired with each other, and the action of 
bundling. The thread/bundle hydration mechanisms involved spraying/misting, the use of 
a humidifier, the application of droplets, or complete submersion in liquid during bundling 
to keep the microthreads well hydrated. 
4.2.1 Bundling Through Twisting 
 The first recorded conceptual design was a simple idea that consisted of two 
concentric, separated circular plates with holes in them to hold and guide the 
microthreads. The two plates would turn counter to each other, resulting in a twist forming 
in the threads in the middle of the gap between the two disks and spreading outwards from 
there. For hydration, simple application of droplets of water or PBS was considered, 
allowing them to run down to the center of the device, at the bundle formation. This 
presented the initial concept of using a rotating plate to create a repeatable twist with the 
threads, as well as using holes to guide the threads. 
 The next design followed a similar bundling procedure of twisting the threads 
together through counter rotations at the two ends of the threads, but was arranged 
horizontally instead of vertically. In addition, the attachment points for both thread ends 
were grouped into small areas. This allowed the potential for a surgical needle to be 
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slipped onto the group of microthreads and for the twisting to occur with the needle in 
place, to simplify the process of twisting the bundle into a suture after being attached to a 
needle. This was the first concept to implement the idea of having a needle in place as the 
bundle/suture is created to remove the attachment step. It was ultimately decided that the 
needle attachment would not be necessary in the final design. 
 Following the theme of twisting the threads together, the next concept came about 
as a result of discussions for potential hydration mechanisms. With the possible hydration 
methods including the system being completely submerged, the idea was presented of 
using the whirlpool effect to achieve the desired twisting. The threads would have been 
suspended into the water, and ideally twisted together into a bundle by a vortex in the 
water, generated by unspecified means. This concept was not pursued, but presented the 
possibility of complete hydration of the threads and the bundling device during the 
bundling process. 
With many simple sketches completed in the pursuit of a reliable design, a more in 
depth and detailed illustration and description was completed for the next conceptual 
design. The mechanism consisted of threaded base rings that would revolve around and 
upwards on a central screwed column, with the threads coming down from a secondary 
piece at the top of the column and attaching to the base disks. The structure included a 
limiter to prevent the possibility of over bundling the threads, as well as a turning knob at 
the edge of the disks for control of the twisting motion. Several possibilities were discussed 
for hydration techniques, and included a mist or spray in various directions, direct 
hydration application to threads through holes, and possible complete system submersion. 
Notable desired aspects in the system were fixed thread position during bundling, a gentle 
interaction to avoid breaking of threads when clamping, and the sliding towards center 
motion. This design really brought out the more advanced device possibilities for the 
twisting mechanism as a way of providing a more comprehensive mechanism for the 
bundling process. 
4.2.2.1 Preliminary Design Mechanisms for Twisting 
Moving back a step, the next design concept was for a bundling system with a simple 
twist as the mode of operation, similar to previous screw ideas. A circular plate with 
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threads feeding up through it would have been fixed to a threaded column, which extended 
outwards below it. The column would have threaded into a base, such that as the column 
moved downwards, it would rotate a fixed amount for the distance traveled, creating a 
consistent and reproducible twist. This design was meant as a way to solidify the twisting 
motion into a device that was deemed reliable and feasible as a potentially simple option to 
execute if the braiding designs were determined to be too complex. 
The next concept that was detailed for a potential twisting mechanism was a hollow 
tube separated into two pieces, designed such that the threaded would pass through the 
tube. As the two halves of the tube were turned counter to each other, the threads would 
bundle into a twist in the center of the tube and the twist would then propagate outwards. 
This concept placed a focus on the idea of having the inside of the tube be a hydration 
chamber for the threads, with the compact design allowing for a potential complete 
submersion. This design was meant as a secondary way to create a twisted bundle such 
that the device allowed for an alternate mode of operation. 
Initially designed with another mechanism in mind, the following concept emerged 
when its original intended mechanisms was seen as being fundamentally flawed. The 
concept revolved around two separated disks, each containing half of the threads, spinning 
counter to each other while one set of threads went around the other set. The idea was 
ultimately seen as not being able to produce the intended bundling upon inspection, but 
instead yielded a different thread bundling technique. The device would result in a double 
twist, such that it contained two sets of threads, each twisting in opposite directions. This 
system introduced the idea of having the double twist in the bundle as an alternative to a 
simple twist, though still not a full braid. This system also continued the theme of being 
about to produce different types of twists with changing out the disks used for attaching 
and twisting the threads. 
4.2.2 Bundling Through Braiding  
For an alternative approach to the bundling procedure, a simple design was 
sketched out that consisted of threads following a sinusoidal track patterned around a disk 
in order to bundle the threads. The motion would have been such that the resulting bundle 
would have been braided in the fashion of a maypole braid, in order to increase the 
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mechanical properties of the final suture. This ultimately introduced the potential of 
combining the threads into a braid for increased strength, as opposed to the currently 
produced twists. 
 From there, the designs progressed to a greater focus on the creation of a system 
that would be able to result in bundling the threads into a braid instead of a twist. A design 
was suggested that was aimed at producing a braid based upon the current techniques for 
braid production that are utilized in the textile industry. The concept focused in on a 
specialized base which would have allowed for multiple threads to be threaded into one of 
several disks inside the base, which would have been rotating about the center with each 
other. The design introduced a potential reliable and concrete method of producing a 
bundle with greater strength than the twisted bundles, as well as being able to create 
different types of bundles in one machine. 
  With a focus on the braiding possibilities, the next conceptual design was planned 
such that it would be possible to produce a braid in the maypole style, a type of braid that 
was shown in literature to be common and effective. The structure of the device would 
have consisted of a series of interconnected gears in a base disk around a center point for 
the threads to twist about, with the thread attachment point being interchanged between 
gears and rotated about the ring. This design also allowed for more than one bundling type, 
along with introducing the maypole braid technique, especially through using a series of 
gears. 
4.3 Preliminary Designs  
After background research into the textile and rope industry, the team noticed a 
common braiding technique across all industries including rope and lace manufacturing. 
The type of braid produced was noted for stronger tensile strength and increased ultimate 
tensile strength. The technique used is called the Maypole braid. In our first conceptual 
design the team set out to build a machine that braided the fibrin microthreads in a 
Maypole braid. The team also came up with several other twisting techniques that do not 
braid in the over under pattern like in the Maypole technique. The team came up with four 
preliminary designs for the suture maker. 
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4.3.1 Maypole Single and Double Braid Design – Preliminary Design 1 
The Maypole machine is utilized in shoelace manufacturing as well as the marine 
rope industry shown in Figure 4. The Maypole braiding machine has a multiplicity of spool 
carriers each provided with follower means arranged to co-act with a fixed circular guide 
track of double undulating and intersecting form and with drive means arranged to engage 
with recesses on horn gears arranged in a circular, meshing array and respectively carried 
on pillars positioned centrally of the individual undulations. Upon driving the horn gears 
the recesses propel the spool carriers along the undulating and intersecting guide track 
such that one group of carriers moves in a circular direction and the other group of carriers 
moves in the opposed circular direction and, following the intersecting undulations, 
alternatingly pass radially inwardly and radially outwardly of each other. Strands of the 
spool carriers are paid off to form a braided sheathing co-axially of the central axis of the 
braiding machine by virtue of the contra-rotating intersecting undulating paths of the spool 
carriers (John R Jones, 1988). 
  
 
4.3.2 Jelly Fish Design – Preliminary Design 2 
Out of the maypole design the group attempted to mimic the sinusoidal path of the 
maypole braiding machines currently available. The design included two separate disks of 
opposing circular motion and was meant to create the maypole braid and is referred to as 
the Jelly Fish Design. Although the design failed to make the maypole braid the resulting 
Figure 4: Maypole machine used in textile and rope industries 
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machine allowed for multiple twists to be made around a center twisted strands. This 
design has been modeled, included as a preliminary design and will be evaluated for 
viability. A simple CAD drawing of this design is show below in Figure 5. 
 
Figure 5: CAD model of Jelly Fish Design – Preliminary Design 2 
4.3.3 Screw and Plate Design – Preliminary Design 
After investigating similar industries and arriving at the Maypole machine and then 
failing in an attempt to modify the maypole design and still achieve a maypole braid 
resulted in a complicated twist technique the team began to brainstorm. In brainstorming 
the current method used by VitaThreads to twist the fibrin microthreads and bearing in 
mind the second preliminary design the team came up with a third design, this design is 
referred to as the Screw and Plate Design. The design comprised primarily of a disc with 
multiple apertures for thread attachment and a screw system intended to maintain equal 
spacing between each twist.  The threads would be fed into the disc via tubes with hold 
them hydrated as the disc spun around the center screw. Below in Figure 6 is a CAD 
drawing depicting the third preliminary design. 
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Figure 6: CAD model of Screw and Plate Design – Preliminary Design 3 
4.3.4 Simple Twist Design – Preliminary Design 4 
The team’s fourth and final preliminary design is mechanically the simplest as it has 
fewest parts. Although the design is simple it achieves the primary function of a suture 
maker.  This design is comprised of two primary parts, two cylinders one with smaller 
diameter so that it can fit inside the other part. Apertures on either end of the cylinders 
allow for insertion and attachment of fibrin microthreads. Slits in the face of the cylinder 
allow the threads to be seen as twisting occurs. The cylinders follow a threaded path and 
the end result is a uniformed twisted bundle of fibrin microthreads. Shown below in Figure 
7 is a CAD drawing of the simple twist design. 
 
Figure 7: CAD model of Simple Twist Design – Preliminary Design 4 
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4.4 Design Modeling 
 To gain a better understanding of the concepts and braiding techniques that were 
involved in the preliminary designs, the team conducted small scale modeling of different 
braiding techniques as well as design concepts.  
4.4.1 Maypole Braiding Technique Modeling  
In order to get a hands-on understanding of the sutures and how it would form a 
maypole braid, the team conducting modeling of the braiding patterns of the maypole 
technique. After braiding once with sutures, the team quickly switched to a thicker material 
of blue yarn to model the fibrin microthread made the braiding much easier to visualize. As 
a team, we modeled a single and double maypole technique braid around a graduated 
cylinder. Figure 8 below shows the single and double braid made out of yarn. From this 
modeling, that the team decided to begin brainstorming the Jelly Fish design shown earlier 
in Figure 5.  
 
 
4.4.2 Design Concept Modeling  
Cardboard was used to build some simple models so that the team could test the 
viability of a conceptual design before building a prototype. A cardboard model of the 
simple twist design was assembled. Cardboard was also used to model the discs for the 
Screw and Plate design as well as the discs for the Double Twist design. Both cardboard 
models are shown below in Figure 9. 
Figure 8: Left - Single yarn braid from Maypole technique. Right - double yarn braid from Maypole 
technique. 
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The team used the software, Solidworks, to build each part and assemble a model of 
each of the alternative designs highlighted above. The team also ordered Lego gears in 
order to assemble the maypole design. Several CAD files the discs were created in 
Solidworks.  
4.5 Feasibility Study and Preliminary Experiments 
In order to gain a better understand of the properties of the fibrin microthreads, the 
team conducted several experiments using threads and bundles provided from 
VitaThreads. The team evaluated the mechanical properties through uniaxial tensile testing 
using Gateway’s Instron Eletropuls e1000 machine and the hydration of the microthread 
through imaging bundles. 
4.5.1 Mechanical Testing – Preliminary Experiment 
 The team preformed uniaxial testing on Gateway’s Instron Eletropuls e1000 
machine, seen below in Figure 10.  
Figure 9: Left - Cardboard model of Screw and Plate Design. Right - cardboard model of Simple 
Twist Design. 
Figure 10: Gateway's Instron Machine used for uniaxial mechanical testing. 
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Samples for this preliminary testing were cut from bundles provided by VitaThreads. Eight 
samples of approximately 5 cm in length were cut from four VitaThreads bundles. The 
samples were left to hydrate overnight (17 hr) before mechanical testing and continuously 
hydrated throughout the testing process. Samples were first imaged using the Leica DM 
LB2 to determine the diameter of the each sample. Five images were taken of each sample, 
and an example of the images taken can been seen in Figure 11. 
 
 
 
The Instron was setup with the 1 N load cell and calibrated to the custom grips used 
for microthread testing. The grips are comprised of a rubber section where the sample is 
laid down across the two grips. The grips are then secured with metal rods placed over the 
rubber portion of the grip and screwed down into place, as seen below in Figure 12. 
Figure 12: A microthread bundle sample loaded into the custom grips used for uniaxial mechanical testing. 
Figure 11: A sample image of taken of a microthread bundle used for mechanical testing 
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Once the sample was loaded into the grips, the grips were then loaded into the Instron 
Eletropuls e1000 machine at WPI’s Gateway Park, as seen below in Figure 13. After the 
sample was in place, the gauge length was measured and the sample was tested until 
failure. The bundles were pulled at a rate of 50% strain per minute.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The Instron raw data and the images from the microscope were used in conjunction 
with a MatLab program to analysis and determine the average diameter, ultimate tensile 
strength (UTS), yield strength (YS), failure strain (FS), and modulus of elasticity (E) for 
each sample. The UTS was calculated as the greatest magnitude of stress that the sample 
experienced, the YS was measured as the point at which the stress-strain curve began to 
exhibit plastic deformation, the FS was the strain at which the sample broke, and the 
modulus was calculated as the slope of the stress-strain curve. In order to determine the 
average diameter, two measurements were taken of each image and the resulting ten 
measurements were averaged together for each sample. A complete protocol for the 
uniaxial mechanical load testing can be found in Appendix C: Instron Testing Protocol for 
Microthread Bundle.  
Figure 13: The sample loaded into the Instron machine ready for 
testing. 
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4.5 Preliminary Data 
4.5.1 Mechanical Testing Results 
The team calculated the UTS, YS, E, and FS for each sample. From the eight samples, 
the mean and standard deviation was calculated for the sample set. These calculated values 
are seen be found in Table 6. 
Table 6: Calculated results of preliminary mechanical testing on microthread bundles. 
 Mean ± SD 
YS (MPa) 0.39 ± 0.19 
UTS (MPa) 1.07 ± 0.68 
FS (mm/mm) 1.33 ± 0.32 
E (MPa) 0.41 ± 0.17 
Diameter (µm) 488.9 ± 150 
Length (mm) 24.88 ± 3.44 
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Chapter 5: Design Verification 
The team used several different tests to determine how consistent the device was to 
the current practices that VitaThreads uses. Three tests were conducted, each to evaluate a 
different desired property of the final system. The three tests were  
 Uniaxial load testing: to determine mechanical properties of the bundles 
 Consistency testing: to determine the consistency of twist in each bundle 
 Cell seedability testing: to determine cell adhesion to bundles 
 
For the mechanical testing and cell seedability testing, control samples were used 
from bundles and sutures prepared by VitaThreads. All additional bundles and sutures 
tested were produce by the design team’s prototype. These three tests were chosen 
because they offered insight about how effectively the prototype was able to fulfill to the 
objectives and functions identified for the design.  
5.1 Mechanical Testing Results 
In order to determine the mechanical properties of the bundles the team’s prototype 
produced, the team conducted uniaxial loading testing on samples and compared the 
results with the preliminary testing done mechanical testing preformed on VitaThreads 
bundles. The team used the same protocol for the testing as previously outlined in 4.5.1 
Mechanical Testing Results; the full protocol for the testing can be seen in Appendix C: 
Instron Testing Protocol for Microthread Bundle. The team used six samples from bundles 
produced by the prototype. During the imaging, one sample broke; the remaining five 
samples were used testing to failure using an Instron Eletropuls e1000 machine. The team 
measured and calculated the mean diameter (μm), gauge length (mm), YS (MPa), UTS 
(MPa), FS (mm/mm), and E (MPa). The mean and standard deviation for each property 
were calculated. Table 7 below shows the mean and standard deviation for all of the 
measured and calculated results for the mechanical testing.  
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Table 7: The mean and standard deviation for the two sample sets for all of the measured and calculate 
mechanical and physical properties. 
 MQP Mean ± SD VitaThreads Mean ± SD 
YS (MPa) 0.20 ± 0.05 0.39 ± 0.19 
UTS (MPa) 0.54 ± 0.18 1.066 ± 0.68 
FS (mm/mm) 1.00 ± 0.43 1.33 ± 0.33 
E (MPa) 0.27 ± 0.16 0.41 ± 0.17 
Diameter (μm) 704.59 ± 55.5 488.94 ± 150 
 
The average diameter of each sample can be seen below in Figure 14. The range of 
values for the prototype samples is smaller than the range for the VitaThreads samples.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14: The calculated mean diameter for each sample and the mean and standard deviation for VitaThreads 
and prototype produced bundle samples. 
 Because of the application of these sutures in the heart, the team identified as most 
important mechanical properties as YS and UTS. Below in Figure 15 shows the calculated 
YS for each sample from the two testing sessions as well the mean and standard deviation 
for each sample set.  
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Figure 15: The calculated yield strength (YS) for each sample and the mean and standard deviation for 
VitaThreads and prototype produced bundle samples. 
Figure 16 below shows the calculated UTS for every sample as well as the mean and 
standard deviation for each set of samples.  
 
Figure 16: The calculated ultimate tensile strength (UTS) for each sample and the mean and standard deviation 
for VitaThreads and prototype produced bundle samples. 
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The team also compared the calculated E values for the two sample sets. Figure 17 below 
shows the calculated E for each sample from the two testing sessions as well the mean and 
standard deviation for each sample set.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17: The calculated modulus of elasticity (E) for each sample and the mean and standard deviation for 
VitaThreads and prototype produced bundle samples. 
5.2 Cell Seedability Testing Results 
 The team conducted testing to determine if the prototype produced bundles that 
were able to seed cells as effectively as the current VitaThreads bundles. The team 
prepared 3 samples from prototype produced sutures and compared them to 4 
VitaThreads samples. These samples were prepared in bioreactor tubing and sterilized 
using ethylene oxide gas. The sterilized samples were then injected with 1cc of hMSCs at a 
concentration of 100,000 cells/100 microns according to the protocol found in Appendix E: 
Protocol for Seeding Fibrin thread bundles with hMSCs using Rotator. The cells were 
passaged to the correct concentration according to the protocol found in Appendix D: Cell 
Culturing and Media Production Protocols. The seven samples were then set in a tube 
rotator and set in an incubator for 24 hours. After 24 hours, the samples were then 
prepared for staining and cell counting. Two methods for these were used for cell counting, 
staining and CyQUANT.  
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For the first method, Phalloidin and Hoescht stains were applied to the samples 
according to the protocol found in Appendix F: Staining Protocol. The samples were imaged 
using the Leica DM LB2 microscope at both 5x and 10x. Using ImageJ, the images were 
merged to show both the Phalloidin and Hoescht stains. The results of the staining method 
did not show any cell adhesion to the prototype produced bundles samples. Inconsistent 
cell adhesion was found on the VitaThreads samples. This cell adhesion inconsistency can 
be seen by the lack of green stain (from the Phalloidin stain) on the left side of the bundle, 
seen below in Figure 18.  
 
The second method for cell counting was a CyQUANT DNA assay. A complete 
protocol for this method can be found in Appendix G: CyQUANT DNA Assay. From this 
assay, limited numbers of cells were found on both the prototype and VitaThreads samples. 
The averages number of cell found on the sutures can be seen below in Table 8.  
Table 8: Average number of cell on sutures per cm for prototype and VitaThreads samples. 
Sample Average number of cells on suture/cm 
Figure 18: VitaThreads bundle sample with Phalloidin and Hoescht stain at 5x magnification. 
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Prototype 629.85 
VitaThread 777.04 
5.3 Consistency Testing Results 
The team also conducted consistency testing on the prototype produced bundles. 
The team used one dyed thread, dyed using trypan blue, in a 12-thread bundle. The sample 
was then imaged using the Amscope 1N300TB microscope in Salisbury Labs at both 5x and 
10x. An examples image of a bundle can be seen below in Figure 19. 
 
  
Eight measurements were made over the length of the sample. Each measurement 
consisted of the amount of twists of the dyed thread counted along a length of 4 mm. A full 
protocol for this experiment can be found in Appendix H: Consistency testing. The mean 
number and standard deviation of twist per cm per sample was then calculated. Figure 20 
below shows the measurements of the frequency of twist in the samples. The mean and 
standard deviation were calculated to be 1.65±0.5 twists per cm per bundle. 
 
Figure 19: A sample bundle being imaged at 5x under the microscope for twist 
consistency testing. 
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Figure 20: Results of the consistency testing showing number of twist per cm for prototype produced bundles. 
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Chapter 6: Discussion 
Once the completed prototype was used to create bundled threads, the bundles 
were subjected to different validation testing procedures to examine their properties. 
Separate bundles were set aside for each of the different validation testing that was 
completed, with tests focusing on the mechanical properties, consistency, and cell 
seedability. It was ensured that different bundles were used for each test, such that the 
results of one test would not be affected by the rigors of the other tests. For mechanical 
properties, bundles were subjected to uniaxial tension testing, stretched to their point of 
failure. Cell seedability was to be tested by seeding equine mesenchymal stem cells 
(eMSCs) on two sets of sutures. One set was produced by our device and the other from 
VitaThreads. These samples were then incubated for 24 and then counted. To check the 
consistency of the other samples bundled by the prototype, one out of the twelve 
microthreads was dyed to examine the thread’s twists throughout the sample.  
6.1 Bundle Mechanics Testing 
 From the data, it can be seen that the mean values for the mechanical properties of 
the device bundled samples are lower than the samples bundles by hand, and the standard 
deviations are also generally lower for the device bundled samples. Using a t-test with a p 
value of <0.05 for statistical significance, measured with p values were found to be 0.05, 
0.12, and 0.17 for the ultimate tensile strength, failure strain, and modulus of elasticity, 
respectively. It can be said that null hypothesis that each pair is comprised of different data 
sets is accurate for the mechanical properties. 
For the standard deviation values, there was a 74%, 73%, 6%, and 63% reduction in 
the standard deviation for the yield strength, ultimate tensile strength, modulus of 
elasticity, and average diameter, respectively. For the standard deviation of the failure 
strain, there was an increase of 32%.  This shows that despite a statistically lower mean 
value between the data sets, the lower standard deviation implies that there was a smaller 
spread in the mechanical properties of the prototype samples, suggesting a more consistent 
microthread bundle. 
 For the mechanical properties, we were willing to accept a slight loss in the strength 
of the bundle if it resulted in an increase in the consistency of the bundle in terms of itself 
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and overall bundle production. The data suggests that this objective was met, as there was 
unfortunate mechanical property loss, but there was also a decrease in the standard 
deviations of the device bundled samples, suggesting an increase in consistency within a 
bundle, and across different bundles. However, there is also the possibility that the change 
in standard deviation could have resulted from the smaller sample size of bundle sections 
from the device. 
 The loss of mechanical properties may further exacerbate the problem of sutures 
breaking at the eye of the needle during surgery, but the device has been designed such 
that the concern could be alleviated through other means. The ability for greater numbers 
of threads, 24 individual threading channels, allows for a greater number of threads to be 
evenly bundled for an ending suture of overall increased strength. In addition, the setup of 
the device that controls the ratio of twists to unit length is consistent across different 
thread counts, allowing continued consistency across bundles of different sizes. 
6.2 Cell Seedability Testing 
 In order to ensure that the automated bundling did not significantly impact the 
bundle’s ability to be seeded with cells, testing was done to examine the adhesion of the 
cells to the microthreads. To prepare the bundle, it was first threaded through a surgical 
needle and twisted to form a suture, and then stored inside bioreactor tubing to be 
sterilized using ethylene oxide gas. After sterilization, the sutures were washed with PBS 
and then cultured in approximately 100 µl of cell media, at a concentration of 100,000 cells 
per 100 µl, and then the sutures were left to seed for a 24 hour period. The cells adhered to 
the samples were then counted using two different methods.  
 Due to an unexpected complication, the samples did not receive the approximate 
amount of CO2. Due to limitations with time and samples, these samples were rinsed of cell 
media and reused for a second run of the experiment. This resulted in the samples being 
hydrated for over 48 hours. From the staining and the CyQUANT assay, all of the samples 
had little to no cell adhesion. This was believed to be related to the change in the protocol 
and the extended hydration period. The relatively close values of average cells per cm for 
the sutures from CyQUANT assay for the two sample sets suggest that the prototype 
samples behaved similar to the VitaThreads under these super hydrated conditions. 
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6.3 Consistency Testing 
 To examine the individual thread consistency within the device manufactured 
bundles, threads were dyed and examined with a microscope. After dying a single thread 
with trypan blue and operating the bundling device as normal, the resulting bundle was 
allowed to dry out and then place on a slide and examined under a microscope. This 
allowed the path of the single dyed thread to be examined in depth, to view and measure 
the amount of twists that the single thread made in a given length. 
 The design team measured the number of twists per cm of the bundles made by the 
prototype. The prototype bundles had a mean of 1.65 twists per centimeter with a standard 
deviation of 0.5. VitaThreads bundles were reported to have an average of 1.5 twists per 
centimeter. As seen above in 5.3 Consistency Testing Results the majority of the twist data 
fell within one standard deviation of the results. Having a low standard deviation and a 
mean close to that of VitaThreads specification of 1.5 twists per cm shows that the 
prototype was successful in producing highly consistent bundles. 
6.4 Impact Analysis 
This design is a prototype, but still has the potential to impact society. The main 
function of this device is to produce microthread bundles for small-scale, laboratory 
production. However, the potential for microthreads to become mass-produced is possible, 
and the device represents the first automated stretching system for fibrin microthreads. 
This device represents a critical step in the full automation of microthread production. The 
following is the team’s analysis of the societal impact of the device.  
6.4.1 Economic impact 
Since our device is designed for laboratory production it has little to no economic 
influence. This device is designed to twist fibrin microthreads into bundles, which will then 
be used to deliver cells to target areas. It is not intended for mass production and therefore, 
our device would not affect the economy of everyday living. 
6.4.2 Environmental Impacts  
     The materials that the team is using to build the device are non-renewable and non-
biodegradable. The parts are comprised of a variety to metals and plastics. Therefore, the 
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production of this design would have a negative impact on the environment. Additionally, 
improper disposal of the parts for this design would have a negative impact on the 
environment. 
6.4.3 Societal Influence  
 This bundling device will not have any societal influence on the general population. 
The device is only designed to twist microthreads into bundles. This process is designed to 
be performed within a clean laboratory environment by trained lab technicians, and thus 
the design will not to be used by the general population. Even in production, sales, or 
marketing, it is expected that mostly medical professionals or companies to be attracted to 
our device. 
6.4.4 Political Ramifications  
 There are no influences that the microthread bundling device would have on the 
global politics. The techniques and uses of microthread sutures are still in a research and 
development stage and are only used in very specific facilities, such as Vitathreads. Thus, 
the device will not have an impact on the global market, nor would it have any influence on 
the cultures of other countries. 
6.4.5 Ethical Concerns  
 While our design does not directly involve the seeding of cells onto the threads, the 
larger production of fibrin microthread sutures involves the seeding of stem cells for 
targeted cell delivery. The stem cells being used are not embryonic stem cells, though the 
use of stem cells is still a highly debated topic due to the ethical concerns surrounding the 
retrieval of stem cells.  
6.4.6 Health and Safety Issue  
 This device is part of a larger operation to produce fibrin microthread sutures for 
cell delivery. Since this operation is not FDA approved yet, there are health and safety 
concerns for the materials being used in this operation. Since biological materials are being 
used to produce the microthreads, these materials need to be well regulated and used 
properly in order to ensure there are no health and safety issues with this device.  
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6.4.7 Manufacturability  
 As of now, our prototype has many parts that we had to find and put together, such 
as rods, gears, and pieces that are rapid prototyped. In terms of complexity, our model is 
not very complicated, but it is not easily built. Since there is not a large market for this 
device, we did not prioritize our model to be easily reproduced. 
6.4.8 Sustainability  
 Since our device is only mechanical at the moment, it is powered by human energy 
using a hand crank system and does not require any electrical energy input. Thus, the 
device will run off renewable energy and will not negatively impact the environment in this 
regard.  
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Chapter 7: Final Design and Validation 
 The problem at hand was to design and build a suture maker that consistently 
produced a bundle of fibrin microthreads that could be easily interfaced with a surgical 
needle and then seeded with stem cells. The current method used by VitaThreads for 
bundling is by hand and a lot of the variances in properties between bundles are attributed 
to this factor. The need for the suture maker to limit those factors ultimately led to an 
exceedingly reproducible bundle. The individual microthreads are extremely fragile and 
must be hydrated throughout the bundling process in order to prevent fracture and ensure 
adhesion between threads. The design of the suture maker must also allow for a varying 
number of threads to be bundled as requested by the client. 
Once the design team had reached a decision on the final design for the suture 
maker through initial concept validation testing, it was important to conduct machine 
validation and bundling validation on the final design. Machine validation would serve to 
affirm that all components of the machine were performing to ensure a consistent twist 
within the final bundle. Bundle validation would serve to confirm that the suture maker 
produced bundles that were more consistent than manually produced bundles while 
maintaining mechanical properties. The controls that were used to test the bundles created 
by the suture maker were bundles made by VitaThreads and the design team. After 
successful validation of the design, the team was able to determine how the suture maker 
had improved the bundling process.  
The MQP project was to be completed and all objectives met within 7 weeks. The 
design team first made Gantt chat, as seen below in Figure 21 to breakdown the work in to 
weekly goals. This allowed the team to orderly complete the project within the allotted 
time. 
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  Week 2 Week 3 Week 4 Week 5 Week 6 
Biweekly 
Writing           
Testing and 
Analysis 
Protocals             
Instron 
Testing 
(Current 
Sutures)           
Cell Culture             
Brainstorming 
Design           
Conceptual 
Designs                 
Evaluation 
Design 
Alternatives           
CAD 
Modeling of 
Design             
Build 
Prototype                  
Prototype 
Testing               
Final Report               
Final 
Presentation               
Figure 21: The design team's Gantt chart for the project. 
7.1 Machine Validation  
The design team arrived at a final decision to use gears and pulleys to create a 
twisted braid after several initial concept experiments. It was important to the team that 
this design allowed the threads to be bundled with a higher consistency between bundles 
and proper thread hydration without any human interaction with the individual threads.  
7.1.1 Thread Path  
In order to ensure that the threads did not interact with each other a set path was 
developed for them. Three discs with up to 24 apertures were created and placed on a 
center axial as guiding holes for this path. The 24 apertures allowed for the suture maker to 
have a variable amount of holes and allowing different number of threads to be bundled. 
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The discs were drawn using Solidworks and rapid prototyped for testing. Several different 
designs were created until arriving at our final disc design; Figure 22 below shows the final 
disc design.  
 
               Figure 22: The final design for the threading discs. 
The initial discs were similar as they had holes, but the loading time proved to be 
tedious and long. In order to cut time out of the bundling process and make the process 
more user friendly, angled slits were cut into the sides of the discs towards each aperture. 
The number of apertures was increased from 12 to 24 to allow more threads to be bundled.  
Also, the initial disc designs were white that made it difficult to see the threads, the team 
made the final discs black as to create a contrast and make the threads more visible during 
loading. Table 9 below summarizes the data from the disc testing. 
Table 9: Results of different threading discs testing. 
Test Disc Type Success/Failure 
1 12 Hole Rapid Prototyped Success 
2 6 Hole Rapid Prototyped Failure 
3 12 Hole Lexen Failure 
4 24 Hole Rapid Prototyped Success 
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7.1.2 Lifting System  
After the development of the discs, the team had to decide on what way the threads 
would be raised through the disc’s apertures. The team ran conceptual tests on a screw 
system but decided that a pulley would be more efficient. In order to have the threads 
moving vertically while rotating and twisting, a pulley was placed above the discs and 
attached to the same crank arm that controlled the rotation of the discs. The crank arm 
turns the discs together as one and also activated the pulley that lifted the threads through 
the discs as the bundle was created. Table 10 below is a summary of the conceptual testing 
done in search of the lifting mechanism.  
 
Table 10: Results of different lifting system testing. 
Test Lifting Mechanism Success/Failure 
1 Screw System Failure 
2 Pulley Success 
 
7.1.3 Guiding Mechanism  
With the development of the pulley lifting system the design team noticed that there 
were some inconsistencies at the initial point of twisting. The team attributed this to 
variability to the vertical point where the initial twist occurred. The issue seen during 
testing was that there was no specific point at which the threads would twist. In order to fix 
this a guiding mechanism was made and placed just above the top disc to provide the 
proper guidance and set a fixed point where each twist would occur. The guidance hole 
above the top disc allows the threads to converge at the same point and ensure the same 
twisting angle between each twist throughout the bundle. Several tests were conducted to 
find the final design of guidance hole. A summary of our data can be seen below in. 
 
 
 
Table 11. 
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Table 11: Results of different guiding mechanism testing. 
Test Guidance Hole Success/Failure 
1 Square shaped Failure 
2 Zip-Tie Success 
3 Circular Success 
 
7.1.4 Hydration 
In the bundling process the hydration of the threads is a very important step. The 
threads were hydrated prior to bundling and then maintained as the twisting occurred. The 
adhesive nature of the fibrin allows them to bond to each other and thus creating a bundle. 
The team tested a number of different hydrating systems as find the most efficient means 
of hydration. Hydration was conducted using a water dropper; the current method used by 
VitaThreads, a mist was also used to hydrate threads via spray bottle. A trough system was 
also used; straws were cut vertically into a “half-pipe” shape and then fitted through the 
disc apertures. The threads hydrated using the trough system and spray system were both 
effective means for hydrating the threads during bundling. The team also attempted to use 
water as we tested the viability of a humidifier, below Table 12 summarizes the results of 
the hydration methods highlighted above throughout the testing period.  
Table 12: Results of different hydration method testing. 
Test Hydration Method Success/Failure 
1 Water Droplets Failure 
2 Spray Bottle Success 
3 Humidifier Failure 
4 Troughs Success 
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7.2 Bundle Validation 
In order to determine the consistency of the bundles produced by the prototype, the 
team used a series of bundles validations tests. The team’s bundle validation included 
mechanical analysis and structural analysis through the testing detailed in Chapter 5 and 6. 
The team determined that these tests were the best options for validating the consistency 
of the bundles due to the time constraints of this project. These tests were chosen because 
similar methods have been used in past studies to better understand the properties of 
microthreads and are similar to quality control methods currently used by VitaThreads. 
7.2.1 Mechanical Analysis 
After the completion of Instron testing it was evident that the design team 
accomplished the objective of creating a suture maker that made consistent bundles of 
similar prosperities. The average YS and UTS seen earlier in Chapter 5: Design Verification 
of the prototyped produced bundles proved to have lower average values but ultimately 
had much lower standard deviations implying that the threads had less variance due to the 
low standard deviations. The data from the Instron testing suggests that the  suture maker 
was successful in achieving Functions 1 and 11 producing a consistent bundle and not 
significantly effecting mechanical properties which can be seen in 3.4.1 Functions. 
7.2.2 Structural Analysis 
 During the prototype testing of the project many bundles were prepared by the MQP 
and assessed for structural analysis. During hydration testing and Instron testing imaging 
was done on the bundles. Using the MatLab program in the Gaudette lab several images 
were assessed for wet diameter. Out of this data an interesting trend arose. The fibrin 
microthread bundles produced by the design team proved to have an overall higher wet 
diameter and a much smaller standard deviation than those prepared by VitaThreads. 
Bundles prepared by the prototype had an average wet diameter of 704.58 ± 55.4 
micrometers and the bundles prepared by VitaThreads had an average wet diameter of 
488.94 ± 150 micrometers. The prototype produced bundles of great diameter with a much 
lower deviation between bundles. The small standard deviation seen in the wet diameter 
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can be attributed to the removal of human role in bundling and indicates that the bundles 
made by the prototype were more consistent. 
 Through the consistency testing detailed previously, the team determined that the 
prototype was able to produce consistency bundles that met the specification of 1.5 twists 
per cm of the design. 
7.3 Final Design 
 After completing validation testing on the machine parts and bundles produced by 
the prototype the design team built in SolidWorks a model of the final design. The final 
design was developed as an improved version of the prototype with parts that would 
address several problems seen throughout the testing period. An emphasis was placed 
upon creating a prototype that was constructed out of standard parts, and was simpler and 
safer to operate. 
For the rotating disks that guided the threads, the final design included a total of 24 
apertures to allow a variable number of threads when bundling, while a guiding hole 
suspended above the uppermost disk allowed all the threads to converge at the same point. 
The pulleys placed above the rotating discs allowed the threads to be lifted directly 
vertically at a controlled rate, as they were hydrated with distilled, deionized water using a 
spray bottle. The pulley is ultimately able to be raised a distance greater than the fourteen 
inches accommodated for the disk system, allowing for a greater length of threads to be 
operated with. 
Mechanically speaking, the LEGO® prototype rotated the disc shaft with an array of 
gears. Appendix I: Initial Prototype Images offers more images of the initial prototype 
designed from LEGOs. In order to simplify the mechanics and create a smoother machine 
the team used a mixture of gears and pulleys within the crank box. In Figure 23 below show 
the prototype with its array of gears and the final design with the changes. A full set of 
images of the second prototype built based off of this final design can be seen in Appendix J: 
Second Prototype Images. 
In the final design, the inclusion of standardized gears and pulley systems allow for 
the parts to be alterable, leaving the potential for them to be changed out at later times. 
This would allow for a different ratio between the ninety degree miter gears, or the two 
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pulleys inside the box, for an adjustable twist per unit length ratio. Further, the 
mechanisms were contained within the polycarbonate housing, serving to protect the gears 
and pulleys from damage, while protecting outside objects from being caught by the 
moving parts to increase the overall safety of the device for users 
 
Figure 23: CAD model of the final design of the bundling device. 
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Chapter 8: Conclusions and Recommendations 
In review, the project and resultant design can be examined such that overall 
conclusions regarding the completed work can be drawn in reference to the outlined 
objectives. The primary goal of the entire project, the production of more consistent 
microthread bundles, resulted from the mechanical bundling of the final design. With 
respect to other properties of the bundles, it was seen that the mechanical properties were 
not significantly impacted, and the cell seedability exhibited adhesion of a similar 
magnitude on bundles produced through different methods. In addition, the device 
mechanics that maintain the amount of twists in a unit length of the bundle allows for the 
further removal of human variability in overall suture production, a goal desired by 
VitaThreads. 
  The results suggest that the threads produced by the bundling device have 
increased consistency throughout and across bundles, while maintaining acceptable 
mechanical properties. The prototype was designed and built to achieve the key functions 
of consistency and reproducible fibrin microthreads bundles through a simple uniaxial 
twisting motion. An initial prototype was developed and testing for proof of concept and 
was able to be used to produce bundles for bundle validation testing. From the testing done 
with the initial prototype, the team was able to improve upon the initial prototype and 
redesign using standardized parts with precise dimensions and measurements to improve 
on the quality of the entire process. Through the prototypes, the team was able to 
successfully achieve the bundling objectives for the design. 
8.1 Recommendations 
 Through the testing of the initial prototype, the team developed several alterations 
that could be applied to future prototypes and designs for the device, but many of these 
could not be completed due to time and budget constraints on the project. For further 
research and testing regarding the construction and layout of the simple twist system, 
considered aspects that could be improved upon include the pulley and in-box belt 
systems, a variable diameter spool, and an overall more accessible box. One 
recommendation the team has for improving the design would be the implementation of an 
accurately sized O-ring for the pulleys inside of the box. An additional recommendation to 
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increase the variability of twisting is the addition of similar pulleys on the spool wheel to 
add a variety in available diameters. This would in turn change how quickly the bundle is 
pulled upwards and therefore change the frequency of the twists in the bundle. The team 
also suggests the addition of a smaller diameter feeder loop to increase it the effectiveness 
of this guiding system. Lastly, the team suggests the addition of a hinge of similar 
mechanism to the closed gear box system to allow for easier maintenance and 
modifications. 
For studies conducted on the bundles produced by the device, it is recommended 
that more data is acquired on the hydration methods compatible with the system, the 
mechanics and consistency of additional bundles, and an in-depth examination of the 
bundling mechanism.  Due to the time and material constraints of the project, the team was 
limited to small samples sizes for all of their testing of the prototypes and design 
mechanisms. The design was greatly improved throughout the design process, and stands 
to further standardize the bundling mechanism with appropriate changes. Potential topics 
of further research could focus on larger sample sizes mechanics and cell seedability 
testing, and analysis of the effects of different angles the threads are bundled at. The team 
also suggests additional research be done on the different application methods and time 
durations of hydration as well as the further developing of the hydration troughs.  
Moving forward with the system, larger scale improvements to the consistency of 
the produced bundles, or an increase of automation that removes the hand crank and 
human feeding, could be applied for producing bundles in a large scale manufacturing 
situation. Alternatively, research could be shifted to examine the potential changes to 
bundles produced through an altered twist or braiding mechanism, to evaluate the effect of 
physical arrangement of threads on the properties of the overall suture. 
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Appendices 
Appendix A: Design Objectives Tree 
 
 
  
Microthread 
bundling device 
Easily attaches to 
needle 
Maintain similar 
properties to 
current suture 
Mechanical 
Properties 
Cell Seedability 
Biocompatibility 
Consistent bundle 
production 
Manufacturability 
Inexpensive 
Can be scaled-up 
User Friendly 
Safe 
Easy to use 
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Appendix B: Design Specifications 
 Produce bundles that can be made into sutures of at least 4 cm in length 
 Can bundle 1-24 microthreads 
 Can bundle microthreads of approximately 12 inches in length 
 Take a maximum of 30 minutes to produce a bundle 
 Produce approximately 1.5 twists/braids per cm 
 Allow thread to bend 90 degrees over 8 cm length 
 Minimize exposed gears and sharp objects 
 Bundle must be similar diameter to current handmade bundles 
 Within two standard deviation to UTS of current bundles 
 Within two standard deviation to YS of current bundles 
 Maintain similar cell seedabililty to current sutures 
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Appendix C: Instron Testing Protocol for Microthread Bundle 
Hydration 
 Hydrate bundles in target solution. This should be done for at least 1 hour. 
 While bundles are hydrating, prepare the Instron and microscope for testing. 
Imaging 
 Prior to testing, take several 5x images of the thread bundle on the Gaudette Lab scope 
a. Lay bundle on an uncharged microscope slide and image the bundle at 5x
 
b. Save pictures in a folder on the desktop being sure to name the files in the form 
Exp15xxx_0001.tif etc. 
c. When all images are taken, CUT and paste the image files onto the Gaudette lab 
drive: ‘\\research.wpi.edu\gaudettelab\Raw Data\Exp15000s\Exp15xxx\’ 
d. DO NOT LEAVE FILES ON THE SCOPE COMPUTER 
 After imaging, return the bundles to the hydration solution 
Setting Up Instron Machine 
 Set up the Instron for testing 
a. CAREFULLY attach the 1N load cell to the Instron and plug it into the back 
b. Turn on Instron controller 
c. Log into Instron computer 
d. Open Instron console 
e. Calibrate the 1N load cell 
f. Attach the right bundle grip to the load cell, balance the load cell (the grip can 
then be removed) 
g. Open the Instron test panels 
h. Open Bluehill 
 Mount the bundle in the bundle grips 
a. Lay bundle across grips 
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b. Tighten one side of grips 
c. Tighten other side of grips
 
d. Return thread and grips to hydration solution 
Initializing the Instron Software 
 Load the Instron test file 
a. In bluehill, go to Test, load the latest Fibrin bundle methods file. 
b. Name the file with the current experiment number (Exp15xxx) and ensure that 
the instron is saving to the ‘G:\Raw Data\Instron raw output’ directory. 
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c. Enter all pertinent information related to the current thread bundle. Make sure 
the specimen label is in the form: ‘Exp15xxx’ 
Loading Instron Machine 
 Load the grips onto the instron
 
a. Attach the correct instron grips on both sides 
b. Extend the instron actuator as far out as possible (Extension on test panel will 
read ~30mm) 
c. Move the crosshead to approximate the grip location with a thread loaded (This 
will take some practice/experience) 
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d. CAREFULLY attach the right thread grip to the 1N load cell. Rest the left grip on 
the lower piece of the left instron grip
 
e. Align the thread linearly in both the vertical and horizontal direction.  
f. Tighten the left side of the thread in the left instron grip 
g. Using the actuator, apply a 10 mN load to the thread. (The viscoelastic properties 
of the thread will dissipate this force over time, this will not affect results.) 
h. In bluehill, reset gauge length 
i. Measure and record the starting length in bluehill 
j. Rehydrate the thread using a transfer pipette 
k. Run the test 
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Appendix D: Cell Culturing and Media Production Protocols 
Materials: 
 Media and media supplements 
o DMEM basal media with high glucose, sodium p 
o yruvate, phenol red, sodium bicarbonate 
o Fetal bovine serum 
o Glutamax (200 mM) 
o Penn-strep (100X) 
 Trypsin (0.25% stock solution; prepare 0.05% working solution) 
 Sterile 1X DPBS (without calcium and phosphate) 
 DMSO (sterile) 
 Sterile tubes and culture plates 
 Incubator (5% CO2; 37°C) 
 Biological Safety Cabinet (BSC) 
 Water bath (37°C) 
 Centrifuge 
 Microscope 
 Serological pipets 
 Motorized pipet aid 
 Vacuum trap 
 Sterilized Pasteur pipets 
 Hemocytometer 
 Solvent resistant markers 
 Spray bottle containing 70% ethanol 
 Kimwipes 
 Gloves 
 
General Procedure: 
 
 Make sure all the materials used for cell culture are sterilized before use. 
 Before and after use, wipe the hood surface with 70% ethanol. 
 Wipe any non-sterilized material with ethanol before placing them in the hood. 
 After using the hood, close the gate and turn on the UV light for at least 20 minutes 
 
Passaging: 
 
1. Receive a 100mm plate of cells from instructor 
2. Make sure the cells are there by looking at them under a microscope 
3. Once the cells look to be about 70%-80% confluent, they are ready to be passaged 
4. Take the complete media and trypsin out of the refrigerator and along with the 
DPBS, place them into the hood, making sure the wipe the bottles with ethanol 
beforehand 
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5. Carefully aspirate the medium with the pasteur pipet and the vacuum tube by tilting 
the plate so that the medium flows into a corner, try not the scratch the bottom of 
the plate where the cells are located. 
6. Wash the plate with 5ml DPBS by pipetting the PBS onto the side of the plate, so that 
the cells are not disturbed. Swirl the DPBS around the plate slowly and then 
aspirate. 
7. Add in 1x trypsin EDTA (~3 mL for a 100 mm plate) and swirl it around the plate. 
Put the plate back into the incubator for 5-10 min to allow for tryspinization. 
8. Take the plate back to the hood and add 2 mL of complete media and pipette up and 
down to break up clumps. Transfer the media into a 15 mL conical tube. 
9. Take the tube and spin the cells down in a centrifuge at 10,000 RPM for 5-10 
minutes. 
10. Take the tube back to the hood and aspirate out the media, be careful not to suck up 
the cells. 
11. Resuspend the cells in 5ml fresh complete media, pipette up and down to break 
clumps. 
12. Obtain a new plate a write your name, the cell type, date, and passage number.  
13. For our purposes, we used a 1:20 dilution so that is 0.250 mL of the 5mL 
14. Add in enough media to the cell media to make a total of 10mL (.250mL + 9.75mL) 
15. Make sure the cells are evenly distributed in the plate and put it back into the 
incubator 
 
Cell Counting: 
 
1. Clean the hemocytometer with 70% ethonal and rinse with water. 
2. Put the coverglass on the hemocytometer and pipette 50uL into the crevice, letting 
the area fill up by capillary action. 
3. Count the cells under a microscope with a counter. 
4. Use the four squares in the corners; count the boxes from left to right, top to bottom. 
5. Divide the total by 4 to obtain the average number of cells per square.  
6. The volume of each square is 100 nl (nanoliters) or 1/10,000 ml. Calculate total 
count per ml as follows. Make sure to take into account the original dilution of cells 
(if applicable) and the dilution used during trypan blue staining. 
7. Calculate the total cell count by multiplying the above figure with the total volume of 
cell suspension from which the sample was drawn 
 
Cell count/ml of suspension = Average count per square x dilution factor x 10,000 
Total count = Cell count per ml x Total volume of suspension 
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Protocol for Production of 100mL Cell Media 
 
Alpha MEM - 78mL 
Horse Serum 10% 10mL 
FBS 10% 10mL 
Glutamax 1x(2mM) 1mL 
P/S 1xStock(100mL) 1mL 
Total Cell Media - 100mL 
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Appendix E: Protocol for Seeding Fibrin thread bundles with hMSCs using Rotator 
Materials: 
 Sterile thread-bundle in Bioreactor 
 Sterile PBS 
 Sterile 1 mL syringe (3) 
 Cell Suspension (100,000 cells/100 µL) 
 50 mL conical tube 
 Tube rotator (fully charged!) 
Procedure: 
1. Use a sterile syringe to inject sterile PBS into bioreactor (by attaching syringe to the 
already inserted 27G needle). 
2. Ensure all bubbles are eliminated from the bioreactor. 
3. Attach slide clamp and remove/discard syringe. (Keep syringe needle in the 
bioreactor). 
4. Allow 20 min for hydration 
5. While bundle hydrates prepare cell suspension according to cell passaging protocol 
6. Use new syringe to expel all sterile PBS from the bioreactor before seeding. For this, 
remove the slide clamp at the end opposite to the needle, draw air into a new sterile 
syringe and push the air into the bioreactor to expel all the PBS.  
7. Use a new syringe (1 cc maximum) to inject cell suspension (100,000 cells / 100 µL) 
into the bioreactor. For this, hold the bioreactor such that the open end of the 
bioreactor (one without slide clamp) remains elevated such that the cell suspension 
doesn’t spill out while being injected.  After 100 µL of cell suspension is injected into 
the bioreactor, close the end opposite the needle by sliding the clamp onto the 
tubing. 
8. After injecting the cell suspension and adding the slide clamp, remove the 27G 
needle from the bioreactor. 
9. Place the bioreactor into a gas permeable 50 mL conical tube. 
10. Place the bioreactor into the MACSmix tube rotator and rotate at 4 RPM (lowest 
setting) for 24 hours. 
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Appendix F: Staining Protocol 
Phalloidin/Hoechst Staining 
Reagents: 
 Phosphate Buffered Saline 
 4% Paraformaldehyde (Only needed for tissues/cells that have not been fixed); 
 0.25% Triton-X 
o 0.25% V/V  Triton-X in PBS 
o 10 μL Triton-X in 3990 μL PBS 
 1% BSA 
o 1% V (W)/V BSA in PBS 
o 40 μL in 3960 μL PBS 
 Phalloidin (AF 488 Phalloidin A12379, Invitrogen) 
o 2.5% V/V Phalloidin in PBS 
o 50 μL in 1950 μL 
 Hoechst 
o 0.0167% Hoechst dye in PBS 
o 0.5 μL in 3000 μL PBS 
 
For unfixed sections/cells: 
1. Rinse in PBS x2 
2. Fix in 4% Paraformaldehyde for 10 minutes 
3. Follow directions for fixed sections 
 
For fixed sections/cells: 
1. Rinse with PBS x2 
2. Triton-X solution for 10 minutes 
3. Rinse with PBS x2 
4. Block with BSA solution for 30 minutes 
5. Phalloidin solution for 30 minutes 
6. Rinse with PBS x2 
7. Hoechst solution for 3-5 minutes (typically 3) 
8. Rinse with PBS x2 
9. Cytoseal and coverslip 
10. Store frozen at -20 degrees C. 
Results: 
 F-actin is stained green and nucleus is stained blue 
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Appendix G: CyQUANT DNA Assay 
Materials 
 DMEM, 10% FBS, 1% P/S (with supplements)  
o Lonza DMEM (Dulbecco’s Modified Eagle’s Medium)  
o FBS (Fetal Bovine Serum) 
o Pen Strep (Penicillin-Streptomycin Solution) 
 Eppendorf Research Pipettes 1mL 
 VWR™ tips for 1mL micropipette 
 Eppendorf Research micropipettes 10µL 
 RT-10F filtered tips for 10µL micropipette 
 Drummond® Pipette Aid  
 VWR™ Serological Pipettes 10ml 
 ISOTEMP 210 Fisher Scientific (Water bath) 
 Thermo Forma Class II A/B3 Biosafety Cabinet 
 70% Ethanol spray bottle 
 ThermoFischer Scientific Hera Cell 150 ThermoElectron Corporation (Incubator 
37°C) 
 Pasteur Pipettes 
 Molecular Probes/Invitrogen #C7026 
 Lysis buffer only #C7027 
 Costar® 3599 96  Well Culture Cluster (96 well plate) 
 DPBS (Dulbecco’s Phosphate buffered saline) 
 Microcentrifuge tube rack 
 Daigger Vortex Genie 2® A. Daigger & Co., INC.  
References 
1. Protocol for general aseptic technique 
2. Protocol for cell harvesting (passaging) 
3. Protocol for cell counting  
4. Protocol for Plate reader 
Dilutions 
1. Using a micropipette, add 1 mL Lysis buffer to 19mL DPBS 
2. Using a micropipette, add 50 µL GR (fluorescent) to 20 mL 1x Lysis buffer   
Method and Analysis  
1. Aspirate off media, using a Pasteur pipette. 
2. Using a micropipette, add 10 mL of DPBS. 
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3. Using a Pasteur pipette, aspirate off DPBS. 
4. Using a micropipette, add 6 mL of trypsin. See protocol for Cell Harvesting 
(Passaging). Read trypsinzation section. Read centrifugation section. 
5. See Cell Counting Protocol. Read entire document. 
6. Using a micropipette, add as much media as necessary to create a cell suspension of 
12,000 cells/100ul  (using/saving 1mL of suspension –final cell #: 120,000/1ml). 
Note: Can change cell concentrations if using/counting larger number of cells. 
7. Centrifuge cell suspension down at 2,000 rpm for 5 minutes using the 
microcentrifuge. 
8. Without disrupting the pellet, remove as much media as possible. 
9. Add 500 µL DPBS. 
10. Centrifuge at 2,000 rpm for 5 min using the centrifuge. 
11. Remove 400 µL.  
12. Freeze at -80°C for at least 1 hour. 
 
Note: The sample can be store up to 4 weeks in a -80°C freezer. 
 
13. In a 96 well plate, place 100 µL of CyQUANT dye/lysis buffer into each well in 
Columns 1-4, Rows B-H.  
14. Add additional 100 µL of CyQUANT buffer to each well of H1-H4.  
15. Remove microcentrifuge tube from freezer. 
 
Note: Allow microcentrifuge tube and contents to reach room temperature. Do NOT 
place in water bath.  
 
16. Vortex lightly using Vortex Genie 2. 
17. When thawing is complete, add 900 µL of CyQUANT buffer to Standard Curve 
microcentrifuge tube. 
 
Note: The total volume in the Standard Curve should be 1000 µL.  
 
18.  Lightly vortex using the Vortex Genie 2®. 
19. Using a micropipette, take up the Standard Curve solution and dispense 200 µL into 
each of the wells A1-A4. 
20. Using a 1000 µL micropipette, take up 100 µL of CyQUANT buffer from the topmost 
well in a Column and dispense it into the well directly beneath it. Mix the solution in 
each well 6 times. Repeat this step through Row G.  
 
Note: Row H wells have NO standard curve (this is blank).  
21. Using a micropipette, add 100 µL of CyQUANT buffer to each well from A1 to G4.    
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a. Note: This will return the full amount to 200 µL. 
 
 Preparation for Sample Analysis 
1. After seeding cells on microthreads and incubating, remove materials from 
bioreactor. 
 
Note: At this point, the cells on the microthreads should be ready to be counted.   
Note: Make sure you have seeded a control thread with just media – this will 
give you a baseline fluorescent reading that your calculations depend on! 
 
2. Using a micropipette, add 500 µL of DPBS. 
3. Centrifuge microcentrifuge tube at 2,000 rpm for 5 minutes. 
4. Using a micropipette, remove 400 µL of DPBS. 
5. Place microcentrifuge tube in microcentrifuge tube rack. 
6. Place rack in -80°C freezer for at least 1 hour 
 
Note: The sample can be store up to 4 weeks in a -80°C freezer. The sample will 
include the thread. Once in freezer, the de-ionized water will lyse the cell 
membrane leaving the DNA behind.  This means no trypsinization is required to 
remove cells from thread.  
 
7. Remove rack from freezer.  
 
Note: Allow microcentrifuge tube and contents to reach room temperature. Do 
NOT place in water bath.  
 
8. Using a micropipette, add 400 µL of CyQUANT lysis buffer. 
9. Vortex lightly using the Vortex Genie 2®. 
10. Using a micropipette, remove material from sample. 
11. Place materials on a slide for staining. 
 
Note: This will confirm cell removal. 
 
12. Using a pipette, take up of solution with cells and dispense 100 µL solutions into 
each of 4 wells.  
13. Once all intended wells are complete,  
14. For de-gassing, place in vacuum. This will remove bubbles.  
15. Place 96 well plate on plate reader. 
16. Run plate reader. (480nm excitation, 520nm absorption) 
 
Note: Samples will saturate after 5 minutes of light exposure; work fast.  
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Should be 200 µL in all wells of standard curve, if not add CyQUANT buffer until 
200 µL is reached.  
 
17. Dispose of waste properly.  
  
Calculations 
1. Place 96 well plate on plate reader. See protocol for Plate reader. Read operation 
related sections. 
2. Copy obtained data into an empty Excel document. Calculate average, correlation 
coefficient, slope, and x-intercept of standard curve. 
 
Note: To calculate the correlation coefficient type in desired cell (the cell 
locations should correspond to cells for calculation) 
 Ex: =CORREL(A3:A10,F3:F10) 
To calculate the average type in desired cell (the cell locations should 
correspond to cells for calculation)  
Ex: =AVERAGE(B3:BE3) 
To calculate the intercept type in the desired cell (the cell locations should 
correspond to cells for calculation) 
Ex: =INETERCEPT(F3:F10,A3,A10) 
To calculate the slope type in the desired cell (the cell locations should 
correspond to cells for calculation) 
Ex: =SLOPE(F3:F10,A3,A10) 
 
3. Using average, multiple the average by 5 for 500µL. 
4. Cell value for sample = (Average – y-intercept)/slope. 
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Appendix H: Consistency testing protocol 
Materials 
 Fibrin microthread bundles 
 Scissors 
 Tape 
 Meter ruler 
 Amscope 1N300TB microscope 
 Clean slide 
 
Procedure 
1. Cut the bundle to 10 cm in length 
2. Tape one cm off at either end of the sample 
3. Place the sample onto a clean glass slide and focus under microscope 
4. Place ruler under microscope so that ruler marking and bundle are both visible 
5. Take eight measurements along the length of the bundle 
a. For each measurement count the number of half twists per 4 mm  
6. Find the mean and standard deviation of twist for the sample 
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Appendix I: Initial Prototype Images 
 
Figure 1: Top view of initial prototype 
 
Figure 2: Side view of initial prototype 
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Figure 3: Front view of initial prototype 
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Appendix J: Second Prototype Images 
 
 
Figure 1: First disc with guiding hole
 
Figure 2: Gears at 90 degree in the base box 
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Figure 3: Pulleys at the top of the device
 
Figure 4: Top view of the base box 
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Figure 5: The three discs that hold microthreads with hanging unit 
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Figure 6: Front view of final prototype 
 
